Wu, H.; Wang, M.-D.; Zhu, J.-Q.; Li, Z.-L.; Wang, W.-Y.; Gu, L.-H.; Shen, F.; Yang, T.
Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine. Pharmaceutics 2022, 14, 1760.
https://doi.org/10.3390/pharmaceutics14091760
AMA Style
Wu H, Wang M-D, Zhu J-Q, Li Z-L, Wang W-Y, Gu L-H, Shen F, Yang T.
Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine. Pharmaceutics. 2022; 14(9):1760.
https://doi.org/10.3390/pharmaceutics14091760
Chicago/Turabian Style
Wu, Han, Ming-Da Wang, Jia-Qi Zhu, Zhen-Li Li, Wan-Yin Wang, Li-Hui Gu, Feng Shen, and Tian Yang.
2022. "Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine" Pharmaceutics 14, no. 9: 1760.
https://doi.org/10.3390/pharmaceutics14091760
APA Style
Wu, H., Wang, M.-D., Zhu, J.-Q., Li, Z.-L., Wang, W.-Y., Gu, L.-H., Shen, F., & Yang, T.
(2022). Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine. Pharmaceutics, 14(9), 1760.
https://doi.org/10.3390/pharmaceutics14091760